Iredell Health System has received the American Heart Association/American
Stroke Association’s Get With The Guidelines®-Stroke Gold Plus
Quality Achievement Award with Target: StrokeSM Honor Roll. This is the
fourth year in a row that Iredell has won the Stroke Gold Plus award and
the first time for the Target: StrokeSM Honor Roll.
“We are excited to receive both of these awards,” said Becky
Quate, RN, Vice President of Nursing and Patient Care.”
The award recognizes the hospital’s commitment and success ensuring
that stroke patients receive the most appropriate treatment according
to nationally recognized, research-based guidelines based on the latest
“With a stroke, time lost is brain lost, and this award demonstrates
our commitment to ensuring patients receive care based on nationally-respected
clinical guidelines,” said Quate. “Iredell Memorial Hospital
is dedicated to improving the quality of stroke care and the American
Heart Association/American Stroke Association’s Get With The Guidelines-Stroke
helps us achieve that goal.”
“We are pleased to recognize Iredell Health System for their commitment
to stroke care,” said Deepak L. Bhatt, M.D., M.P.H., national chairman
of the Get With The Guidelines steering committee and Executive Director
of Interventional Cardiovascular Programs at Brigham and Women’s
Hospital and Professor of Medicine at Harvard Medical School. “Studies
have shown that hospitals that consistently follow Get With The Guidelines
quality improvement measures can reduce length of stay and 30-day readmission
rates and reduce disparities in care.”
To receive the Gold Plus Quality Achievement Award, hospitals must achieve
85 percent or higher adherence to all Get With The Guidelines-Stroke achievement
indicators for two or
more consecutive 12-month periods and achieved 75 percent or higher compliance
with five of eight Get With The Guidelines-Stroke Quality measures.
To qualify for the Target: Stroke Honor Roll, hospitals must meet quality
measures developed to reduce the time between the patient’s arrival
at the hospital and treatment with the clot-buster tissue plasminogen
activator, ortPA, the only drug approved by the U.S. Food and Drug Administration
to treat ischemic stroke. If given intravenously in the first three hours
after the start of stroke symptoms, tPA has been shown to significantly
reduce the effects of stroke and lessen the chance of permanent disability.
Iredell Health System earned the award by meeting specific quality achievement
measures for the diagnosis and treatment of stroke patients at a set level
for a designated period.
These quality measures are designed to help hospital teams provide the
most up-to-date, evidence-based guidelines with the goal of speeding recovery
and reducing death and disability for stroke patients.
According to the American Heart Association/American Stroke Association,
stroke is the number five cause of death and a leading cause of adult
disability in the United States. On average, someone suffers a stroke
every 40 seconds; someone dies of a stroke every four minutes; and 795,000
people suffer a new or recurrent stroke each year.